MAHONEY DAVID L sold 8.4% of their position (103.61K shares) of CORCEPT THERAPEUTICS INC on the open market
Open‑market sale worth $12.25M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 8/20/2026ACC: 0001193125-26-359255
-103.61K
Net shares
Net seller
$12.25M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
103.61K disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−4.98K
Price / share
$117.47
Trade value
$585.48K
% of position
0.4%
8/18/2026
1.24M→1.23M
Common Stock
Indirect
Shares
−91.17K
Price / share
$118.24
Trade value
$10.78M
% of position
7.4%
8/18/2026
1.23M→1.14M
Common Stock
Indirect
Shares
−7.05K
Price / share
$118.88
Trade value
$838.71K
% of position
0.6%
8/18/2026
1.14M→1.13M
Common Stock
Indirect
Shares
−400.00
Price / share
$119.64
Trade value
$47.86K
% of position
0.0%
8/18/2026
1.13M→1.13M
Total
Net shares
−103.61K
Net value
-$12.25M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/18/2026 | S · Sale | −4.98K | $117.47 | $585.48K | 0.4% | 1.24M | 1.23M |
| Common Stock Indirect | 8/18/2026 | S · Sale | −91.17K | $118.24 | $10.78M | 7.4% | 1.23M | 1.14M |
| Common Stock Indirect | 8/18/2026 | S · Sale | −7.05K | $118.88 | $838.71K | 0.6% | 1.14M | 1.13M |
| Common Stock Indirect | 8/18/2026 | S · Sale | −400.00 | $119.64 | $47.86K | 0.0% | 1.13M | 1.13M |
| Total | −103.61K | -$12.25M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned26.15K
Total
26.15K indirect26.15K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 26.15K | Indirect |
| Total | 26.15K | 26.15K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported